Accumulation of glucosylceramides in multidrug-resistant cancer cells
about
Killing tumours by ceramide-induced apoptosis: a critique of available drugsSphingolipid perturbations as mechanisms for fumonisin carcinogenesis.Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic moleculeTamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsA new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosisMetabolomics coupled with multivariate data and pathway analysis on potential biomarkers in gastric ulcer and intervention effects of Corydalis yanhusuo alkaloidExtended ultrastructural characterization of chordoma cells: the link to new therapeutic optionsTrafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-alphaDynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemiaModification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.Differential expression of sphingolipids in MRP1 overexpressing HT29 cells.Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice.Re-configuration of sphingolipid metabolism by oncogenic transformation.Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinomaCeramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Augmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systemsExpanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype.Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth.Recent developments in the cell biology and biochemistry of glycosylphosphatidylinositol lipids (review).Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens.Caveolin-1: a tumor-promoting role in human cancer.Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases.Cancer chemotherapy--ribonucleases to the rescue.Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines.Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseasesInhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.Apoptotic sphingolipid ceramide in cancer therapy.P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.Colon cancer: genomics and apoptotic events.Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia.Reticulon Protein-1C: A New Hope in the Treatment of Different Neuronal Diseases.Lipidomic approach for stratification of acute myeloid leukemia patients.Mechanisms and strategies to overcome multiple drug resistance in cancer.The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activityResistance to the new anti-cancer phospholipid ilmofosine (BM 41 440)Sphingolipids: regulators of crosstalk between apoptosis and autophagyEffects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells.Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells
P2860
Q24529892-543A5AD3-B642-46CA-866D-88E1D0A967D0Q24537114-F39537B5-FF99-48D4-B9DA-441F5B6D9362Q27335599-F7C5DC39-906E-4CBB-A474-B0FE3EE648BBQ28084270-64ACE4CC-76F8-4BB4-B490-B7BACAE41110Q28476087-DA2BFAF5-A73E-47A7-9BE9-33A702753B24Q28538684-B3170648-E18F-418F-9B26-E096E6FCEAC5Q28542546-1B692CA8-D99A-44AA-AE2A-47978D68F88BQ28572338-7AF3044D-B73C-4C0A-B20D-A96599A9FD28Q30278944-4C6FE703-AA59-44FB-AEF6-838F49528406Q30300370-1429D2E1-C274-421E-9176-899ED9D92891Q30881625-BEA748D5-728C-43BC-A893-4B6E7E3982FBQ30881683-EE261B26-8285-4A55-B796-D6EACBE0EDBFQ33649823-BC1308E2-6E97-42F1-BF0C-CF35E9BCABEBQ33683147-9636E2A9-C583-4CB8-81E1-DD73687A085AQ33733991-15755F74-4F9F-476F-B7A5-D0DAD46133B8Q33749449-A5FA9570-278D-486D-9757-7F0BC84B24CAQ33874873-0BED54AB-D292-4DDC-A167-CBF6948966C3Q33893675-06E44A7C-8C08-446E-8C6B-CCFC0134DB15Q33902904-9F4C36C0-4BFA-46A7-87CB-2A2732E96C69Q33914230-0F6604D2-B50C-4831-9991-E1691F7734B3Q34010128-8CE50794-7F01-4FB9-9881-17E6068458FFQ34129373-54D42007-70A5-4745-BBAD-426DF94D93C0Q34254671-5CE40259-A9C0-42D6-B2B0-E2270D790129Q34295244-4806465A-3F6A-44B8-B5B3-44D7CC4DF63FQ34302997-85467DC9-AE7C-4BAC-8480-D933D78CE6EFQ34334511-6DCB1055-2DBC-4712-BCB7-72609202DE37Q34736760-DE70E408-6D5D-4293-A415-0E31AE96822BQ35057879-D6FF7850-7FBD-47D9-99C4-63474D01227BQ35324757-E7A29E81-769E-4285-8CD9-2495CE8EB07FQ35600076-8E434EB1-CF02-4D70-977B-1A1740A56BECQ35837213-1CA7165E-1156-4EEE-939A-54D434675748Q35918060-45FE000F-DBF6-409D-83B0-28D7F01E1608Q36010989-40111410-DCAF-4610-9480-FC70F86015F3Q36282427-C0949FDB-BEE7-496F-911F-CE45BFD394EDQ36404538-859E1334-48CB-4E53-B0C3-1456003BD361Q36404904-A4E4586E-415F-42C9-8E47-4DA9C4312CDEQ36431160-D82DA864-BB8C-4266-BD6D-CBF4CF6DA183Q36462123-BAE27B8D-FE79-4B13-BC76-ECE509701207Q36492334-2424948B-4DFD-4292-8F37-A0C1A9552EA4Q36600615-0A861819-028A-4C0F-BC99-B6704FD47C56
P2860
Accumulation of glucosylceramides in multidrug-resistant cancer cells
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@ast
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@en
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@nl
type
label
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@ast
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@en
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@nl
prefLabel
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@ast
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@en
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@nl
P2093
P3181
P356
P1476
Accumulation of glucosylceramides in multidrug-resistant cancer cells
@en
P2093
P304
P3181
P356
10.1074/JBC.271.32.19530
P407
P577
1996-08-09T00:00:00Z